Previous 10 | Next 10 |
NEW YORK , Nov. 11, 2019 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – will host its Disruptive Innovation Summit: FinTech, Blockchain & AI at the Palace Ho...
LONDON and FRANKFURT, Germany , Nov. 1, 2019 /PRNewswire/ -- Oppenheimer & Co Inc.* ("Oppenheimer") a leading global investment bank and wealth manager is pleased to announce the appointment of Lars Dürschlag as Managing Director Germany within its EMEA Investment Banking ...
Oppenheimer Holdings (NYSE: OPY ): Q3 GAAP EPS of $0.29. More news on: Oppenheimer Holdings Inc., Earnings news and commentary, Financial stocks news, Read more ...
NEW YORK , Oct. 25, 2019 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company") today reported net income of $3.9 million or $0.31 basic net income per share for the third quarter of 2019 compared with net income of $5.1 million or $0.38 basic net income per share fo...
NEW YORK , Oct. 10, 2019 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – will host its Houston Oncology Summit on October 17, 2019 at the University ...
NEW YORK , Oct. 7, 2019 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – today announced that Suraj Kalia has joined the Firm as Managing Director and Senio...
NEW YORK , Oct. 1, 2019 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – today announced that Fernando Losada has joined the Firm as Managing Director, Head...
Investment banks generate handsome revenues by advising and facilitating the financing of innovative biotech and life sciences companies . Most research and development stage biotechs produce no revenue, causing them to regularly return to investors for additional capital. With drug development...
NEW YORK , Sept. 20, 2019 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – will host its two-day Fall Summit Focused on Specialty Pharma and Rare Disea...
NEW YORK , Sept. 16, 2019 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – will gather innovative companies, institutions and individuals from across the cybe...
News, Short Squeeze, Breakout and More Instantly...
Oppenheimer Holdings Inc. Class A Company Name:
OPY Stock Symbol:
NYSE Market:
Oppenheimer Holdings Inc. Class A Website:
Oppenheimer Holdings Inc. Reports Second Quarter 2024 Earnings Canada NewsWire NEW YORK , July 26, 2024 /CNW/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $10.3 million or $0.99 basic earnings per share fo...
Oppenheimer Announces Additions to the High Yield and Distressed Debt Team PR Newswire Strategic Recruitment of 10 New Hires Builds on Oppenheimer's Momentum as the Credit Landscape and Macroeconomic Trends Signal Greater Demand for Leveraged Finance NEW YORK ...
Oppenheimer & Co. Inc. Appoints Andreas Argyrides As Executive Director and Senior Analyst Covering the Biotechnology Sector Oppenheimer & Co. Inc. Appoints Andreas Argyrides As Executive Director and Senior Analyst Covering the Biotechnology Sector PR Newswire E...